14 evolution "https:" "https:" "https:" "https:" "https:" "University of St" uni jobs at Nature Careers in Switzerland
Sort by
Refine Your Search
-
generations to come. Join Roche, where every voice matters. The Position This role is in Early Development Biometrics (EDB), a core function within Product Development Data Sciences (PDD) that provides
-
-of-the-art facilities and infrastructure, plus a mentorship program. The position is an attractive springboard for scientific and career development. ELISIR scholars are not tenured and appointed
-
responsible AI development, • lead institutional development, including fundraising, strategic alliances with academic and industrial partners, and engagement with public stakeholders
-
, preferably Neuroanatomy, and using model systems relevant to human development or disease. You will also be expected to secure competitive research funding and publish high-quality papers in your field
-
expertise in the use and development of AI-based approaches for image and data analysis. A general understanding of methods for in silico prediction, modeling, or data integration and/or of experimental
-
may be contacted directly by the committee). Letters of recommendation are not required at this stage. Applications must be submitted exclusively online at https://jobs.unige.ch by 1st March 2026
-
within the NCCR Evolving Language and strongly contribute to its scientific development and broader agenda. Administrative responsibilities within the Department of Basic Neurosciences and the Faculty
-
of material science. Examples are the use and development of muon instrumentation for the study of quantum and energy materials. The research program of this new professorship will be able to take advantage
-
collaboration with medical research communities in Basel and Zurich. The future Assistant Professor will bring unique, multidisciplinary expertise in computational immunology, contributing to the development
-
generations to come. Join Roche, where every voice matters. The Position In Roche’s Pharmaceutical Research and Early Development organization (pRED), we make transformative medicines for patients in order to